GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women

Part of paid clinical trials in Kansas City, Kansas.

Sponsor
University of Kansas Medical Center
Study ID
NCT07422987
Status
Recruiting

Conditions

  • Body Composition
  • Estrogen Level
  • GLP-1
  • Muscle Function

Eligibility Criteria

Sex
FEMALE
Age
35 Years - 60 Years
Healthy Volunteers
Accepted

Study Details

This study is designed with the interest to learn on the effects of estrogen levels and how it affects body compositions and muscle function in midlife women who are taking a GLP-1RA for weight loss.

Key Dates

Start date
Feb 12, 2026
Status verified
Feb 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
50 participants (estimated)

Arms

  • Arm: GLOW Participants
    New patients, those who are newly prescribed a GLP-1RA medication will be invited to participate in the study where different measurements will be completed to assess body composition, hormone levels, muscle strength and nutrition.

Primary Outcome Measure

Body weight [ Time Frame: Baseline through 6-month visit ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
The University of Kansas Medical CenterKansas CityKansas66160-

Find similar trials in Kansas City, KS

Related Studies